Your browser doesn't support javascript.
loading
Harnessing radiotherapy-induced NK-cell activity by combining DNA damage-response inhibition and immune checkpoint blockade.
Patin, Emmanuel C; Dillon, Magnus T; Nenclares, Pablo; Grove, Lorna; Soliman, Heba; Leslie, Isla; Northcote, Davina; Bozhanova, Galabina; Crespo-Rodriguez, Eva; Baldock, Holly; Whittock, Harriet; Baker, Gabriella; Kyula, Joan; Guevara, Jeane; Melcher, Alan A; Harper, James; Ghadially, Hormas; Smith, Simon; Pedersen, Malin; McLaughlin, Martin; Harrington, Kevin J.
Afiliación
  • Patin EC; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK emmanuel.patin@icr.ac.uk.
  • Dillon MT; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.
  • Nenclares P; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.
  • Grove L; Head and Neck Unit, Royal Marsden Hospital NHS Trust, London, UK.
  • Soliman H; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.
  • Leslie I; Head and Neck Unit, Royal Marsden Hospital NHS Trust, London, UK.
  • Northcote D; Head and Neck Unit, Royal Marsden Hospital NHS Trust, London, UK.
  • Bozhanova G; Head and Neck Unit, Royal Marsden Hospital NHS Trust, London, UK.
  • Crespo-Rodriguez E; Head and Neck Unit, Royal Marsden Hospital NHS Trust, London, UK.
  • Baldock H; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.
  • Whittock H; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.
  • Baker G; Biological Services Unit, The Institute of Cancer Research, London, UK.
  • Kyula J; Biological Services Unit, The Institute of Cancer Research, London, UK.
  • Guevara J; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.
  • Melcher AA; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.
  • Harper J; Head and Neck Unit, Royal Marsden Hospital NHS Trust, London, UK.
  • Ghadially H; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.
  • Smith S; Early Oncology R&D, AstraZeneca, Cambridge, UK.
  • Pedersen M; Early Oncology R&D, AstraZeneca, Cambridge, UK.
  • McLaughlin M; Early Oncology R&D, AstraZeneca, Cambridge, UK.
  • Harrington KJ; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.
J Immunother Cancer ; 10(3)2022 03.
Article en En | MEDLINE | ID: mdl-35314434
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ataxia Telangiectasia / Neoplasias de la Boca / Carcinoma de Células Escamosas / Infecciones por Papillomavirus / Neoplasias de Cabeza y Cuello Tipo de estudio: Clinical_trials Límite: Animals / Humans Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ataxia Telangiectasia / Neoplasias de la Boca / Carcinoma de Células Escamosas / Infecciones por Papillomavirus / Neoplasias de Cabeza y Cuello Tipo de estudio: Clinical_trials Límite: Animals / Humans Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido